180 Life Sciences Stock Jumps on $156 Million Notes Sale

Dow Jones
Aug 12, 2025

By Dean Seal

 

Shares of 180 Life Sciences climbed after the company sold $156 million in convertible notes in order to load up its ether reserves.

The stock was up 11% at $3.32 in afternoon trading. Shares have now gained 83% since the start of the year.

The dietary supplement and food ingredient company said before the opening bell that it has sold $156 million worth of senior secured convertible notes due 2028 in a private offering.

The notes have a conversion price of $3.445 a share, subject to a one-time downward reset on the nine-month anniversary of the notes issuance if the closing price on that date is less than the conversion price.

Proceeds will be used to buy more ether for the company's ethereum treasury strategy.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

August 11, 2025 13:34 ET (17:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10